News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • SpaceX's U.S. IPO vaulted its market value past $2 trillion, prompting calls to expand the 'Magnificent Seven' mega-cap list.
  • Broadcom warned gross profit margins will keep falling, exposing the stock to downside despite strong fundamentals and AI demand.
  • Bank of America warns a U.S.-Iran deal could leave oil higher, keeping inflation elevated and deterring Federal Reserve rate cuts.
  • Intellia reported Phase 3 results showing an 87% reduction in HAE attacks, filing for FDA review with potential 2027 U.S. approval.
  • Texas's Senate race turned competitive after Ken Paxton's upset, and GOP strategists are pressing Trump to deploy funds to shore up Paxton.
  • Hotels near MetLife Stadium hiked rates for the 2026 World Cup but report lower-than-expected bookings, signaling subdued fan travel demand.

Latest Articles

Electra Awards Structural, Mechanical & Piping Contract

Electra Awards Structural, Mechanical & Piping Contract

Electra Battery Materials has awarded a $12.4 million contract to Kilmarnock Enterprises for structural, mechanical, and piping work at its cobalt sulfate refinery north of Toronto, supporting its strategy to develop a domestic EV battery materials supply chain. This contract is part of approximately $46 million in awarded construction packages, wi…

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Fractyl Health announced positive one-year results from its open-label REVEAL-1 study showing that participants maintained approximately 78% of their GLP-1-induced weight loss after discontinuing GLP-1 therapy following a single Revita procedure. The procedure demonstrated excellent safety, sustained glycemic control, and potential as a durable, mi…

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Ovid Therapeutics Inc., a biopharmaceutical company specializing in treatments for brain disorders with significant unmet needs, announced its management will participate in two upcoming investor conferences. The presentations will provide updates on their pipeline, including therapies targeting treatment-resistant seizures and neuropsychiatric dis…

Orion Reports FY 2026 Revenue of $86M and Adjusted EBITDA of $2.2M After Continued Growth in Q4; Reiterates FY 2027 Expectation of $95M-$97M in Revenue and Positive Adjusted EBITDA

Orion Reports FY 2026 Revenue of $86M and Adjusted EBITDA of $2.2M After Continued Growth in Q4; Reiterates FY 2027 Expectation of $95M-$97M in Revenue and Positive Adjusted EBITDA

Orion Energy Systems, Inc. (NASDAQ: OESX), a provider of energy-efficient LED lighting, EV charging stations, and maintenance services, announced its fiscal 2026 results featuring $86.3 million in revenue, an 8% increase year-over-year, and positive adjusted EBITDA of $2.2 million after six consecutive quarters of profitability. The company reporte…

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

BeyondSpring Inc., a clinical-stage biopharmaceutical company, announced a strategic leadership transition effective July 1, 2026, to focus on executing its confirmatory DUBLIN-4 Phase 3 trial for Plinabulin in non-squamous EGFR wild-type NSCLC patients. The company appoints Min Qiu as CEO with a mandate to complete DUBLIN-4, extend Plinabulin's sc…

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting

Axsome Therapeutics presented new clinical data on SYMBRAVO®, its investigational migraine treatment, at the American Headache Society 68th Annual Scientific Meeting. The data highlights SYMBRAVO's efficacy and safety in acute migraine treatment from multiple studies, supporting its potential market impact in CNS disorder therapeutics. Axsome conti…

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

AEON Biopharma announced presentation of new analytical and functional data at the 68th Annual Scientific Meeting of the American Headache Society demonstrating structural and functional comparability of its biosimilar candidate ABP-450 to BOTOX®. The data reinforce biosimilarity using multiple analytical methods, supporting AEON's pursuit of full-…

Plug to Webcast Annual Shareholder Meeting on June 11, 2026

Plug to Webcast Annual Shareholder Meeting on June 11, 2026

Plug Power Inc. announced its annual shareholder meeting webcast will take place on June 11, 2026, featuring a presentation by CEO Jose Luis Crespo on the company’s corporate overview and operations in the hydrogen economy. The webcast is accessible to shareholders and the public, highlighting Plug Power's progress in hydrogen solutions, electrolyz…

3D Systems Stock Plunges After Company Prices $50 Million Follow-On Offering

3D Systems Stock Plunges After Company Prices $50 Million Follow-On Offering

Shares of 3D Systems Corp tumbled more than 14% in premarket trading after the company priced a $50 million follow-on offering. The Rock Hill, South Carolina-based 3D printer maker sold roughly 16.4 million shares at $3.05 apiece, an increase from an initially planned $40 million and a 15.5% discount to the prior close. The company said net proceed…

RTX Rises on Navy Radar Award and Jefferies Upgrade

RTX Rises on Navy Radar Award and Jefferies Upgrade

RTX climbed in pre-market trading after Raytheon secured a $515 million U.S. Navy contract for SPY-6 radar systems and Jefferies upgraded the stock to Buy with a higher price target. The contract supports production ramp-up plans and the analyst upgrade raised near-term EPS forecasts and valuation assumptions, helping the stock outperform a retreat…

Summer Haze: Markets Pause as Tech Rally Faces Early Strains

Summer Haze: Markets Pause as Tech Rally Faces Early Strains

U.S. and global markets showed signs of cooling after a streak of gains as Broadcom’s earnings fell short of lofty expectations and commodity and macro indicators stirred fresh caution. Strong activity readings and persistent energy price pressures have kept hawkish rate bets alive, while geopolitical tensions and private markets stress add to near…

BofA and Barclays Lift ASML Targets as EUV Capacity Prospects Improve

BofA and Barclays Lift ASML Targets as EUV Capacity Prospects Improve

BofA Securities and Barclays both raised price targets for ASML on June 4, pointing to stronger demand visibility into 2028 and mounting evidence that the Dutch lithography specialist can boost extreme ultraviolet (EUV) capacity despite present constraints. The upgrades reflect higher unit forecasts, revised financial models and supplier hiring sig…

Crypto equities slide as Bitcoin falls to nearly four-month low

Crypto equities slide as Bitcoin falls to nearly four-month low

Bitcoin tumbled to its lowest level in almost four months, pressured by geopolitical anxiety, sizeable institutional redemptions from U.S. spot Bitcoin ETFs and a corporate seller’s first disposal of Bitcoin in years. The cryptocurrency’s decline pulled down shares of crypto-related firms, from exchangers to miners, as investors rotated capital int…

Parabilis Medicines Files for U.S. IPO Targeting $475 Million

Parabilis Medicines Files for U.S. IPO Targeting $475 Million

Parabilis Medicines has submitted an S-1 to pursue a U.S. initial public offering of up to $475 million, proposing 25 million shares at $17 to $19 apiece and a Nasdaq listing under the symbol PBLS. Regeneron Pharmaceuticals has agreed to buy about $75 million of common stock via a concurrent private placement. The company outlined planned use of pr…